All clinically effective antipsychotics have a common mechanism of action involving the blockade of D2 dopamine receptors; however, the typical ones are more potent dopamine D2 receptor antagonists and, thus, cause more pronounced side effects such as hyperprolactinemia and extrapyramidal symptoms (EPS). The gene discussed is DRD2; the disease is hyperprolactinemia.